Related Experiment Video
Updated: Feb 3, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review
Pamela D Browne1, Sjoerd C J Nagelkerke1, Faridi S van Etten-Jamaludin2
1a Emma Children's Hospital, Amsterdam UMC , University of Amsterdam, Pediatric Gastroenterology , Amsterdam , The Netherlands.
Insights
Pharmacological treatments for pediatric functional dyspepsia (FD) show mixed results, with some drugs offering symptom relief but lacking strong evidence. More high-quality trials are needed to confirm efficacy and safety for children with FD.
Area of Science:
- Pediatric Gastroenterology
- Pharmacology
- Evidence-Based Medicine
Background:
- Chronic idiopathic nausea (CIN) and functional dyspepsia (FD) significantly impact children's quality of life.
- Current evidence on pharmacological treatments for pediatric CIN and FD is limited.
- Systematic reviews are crucial for assessing treatment efficacy and safety in pediatric populations.
Purpose of the Study:
- To systematically review the efficacy and safety of pharmacological treatments for CIN or FD in children aged 4-18 years.
- To evaluate the quality of evidence from randomized controlled trials (RCTs) for these conditions.
- To identify gaps in research and guide future clinical investigations.
Main Methods:
- Searched CENTRAL, EMBASE, and Medline databases for relevant RCTs.
- Included studies focused on children aged 4-18 years with CIN or FD.
- Assessed the methodological quality of included studies using the Cochrane risk of bias tool.
Main Results:
- Three RCTs involving 256 children with FD (aged 2-16 years) were included; no studies for CIN were found.
- All included studies exhibited a considerable risk of bias, necessitating cautious interpretation of results.
- While some drugs like famotidine showed potential benefits in symptom improvement compared to placebo, overall evidence remains weak.
Conclusions:
- The current systematic review found insufficient evidence to support the use of pharmacological drugs for treating CIN or FD in children.
- Existing studies have significant limitations, including a high risk of bias.
- Further high-quality randomized controlled trials are essential to establish effective and safe pharmacological interventions for pediatric functional gastrointestinal disorders.
Introduction:
Chronic idiopathic nausea (CIN) and functional dyspepsia (FD) cause considerable strain on many children's lives and their families. Areas covered: This study aims to systematically assess the evidence on efficacy and safety of pharmacological treatments for CIN or FD in children. CENTRAL, EMBASE, and Medline were searched for Randomized Controlled Trials (RCTs) investigating pharmacological treatments of CIN and FD in children (4-18 years). Cochrane risk of bias tool was used to assess methodological quality of the included articles. Expert commentary: Three RCTs (256 children with FD, 2-16 years) were included. No studies were found for CIN. All studies showed considerable risk of bias, therefore results should be interpreted with caution. Compared with baseline, successful relief of dyspeptic symptoms was found for omeprazole (53.8%), famotidine (44.4%), ranitidine (43.2%) and cimetidine (21.6%) (p = 0.024). Compared with placebo, famotidine showed benefit in global symptom improvement (OR 11.0; 95% CI 1.6-75.5; p = 0.02). Compared with baseline, mosapride versus pantoprazole reduced global symptoms (p = 0.011; p = 0.009). One study reported no occurrence of adverse events. This systematic review found no evidence to support the use of pharmacological drugs to treat CIN or FD in children. More high-quality clinical trials are needed.
Abbreviations:
AP-FGID: Abdominal Pain Related Functional Gastrointestinal Disorders; BART: Biofeedback-Assisted Relaxation Training; CIN: Chronic Idiopathic Nausea; COS: Core Outcomes Sets; EPS: Epigastric Pain Syndrome; ESPGHAN: European Society for Pediatric Gastroenterology Hepatology and Nutrition; FAP: Functional Abdominal Pain; FD: Functional Dyspepsia; GERD: Gastroesophageal Reflux Disease; GES: Gastric Electrical Stimulation; H2RAs: H2 Receptor Antagonists; IBS: irritable bowel syndrome; NASPGHAN: North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; PDS: Postprandial Distress Syndrome; PPIs: Proton Pump Inhibitor; PROMs: Patient Reported Outcome Measures; RCTs: Randomized Controlled Trials; SSRIs: selective serotonin reuptake inhibitors; TCAs: tricyclic antidepressants.
Related Concept Videos
Functional Groups
Functional Groups
Functionalism
James envisioned psychology's...
Mechanical Protein Functions
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Hyperbolic Functions

